Releases
| Title | Date | Size | View |
|---|---|---|---|
| Appendix 4C: Quarterly report for entities subject to Listing Rule 4.7B | April 17, 2019 | 169 KB | Download |
| 73% Increase in DyeVert First Quarter Unit Sales | April 17, 2019 | 319 KB | Download |
| Notice of Annual Meeting of Stockholders & Proxy Statement | April 11, 2019 | 3 MB | Download |
| Quarterly Results and Investor Conference Call Notification | April 8, 2019 | 237 KB | Download |
| Appendix 4G | March 26, 2019 | 183 KB | Download |
| Significant DyeVert™ Clinical Data Featured at ACC and ACC Quality Summit Annual Meetings | March 20, 2019 | 289 KB | Download |
| Osprey Appoints Mr. Jim Surek as Vice President, Sales | March 4, 2019 | 241 KB | Download |
| Osprey Medical Preliminary Final Report and Consolidated Financial Statements | February 26, 2019 | 879 KB | Download |
| ASX ANNOUNCEMENT – 2019 Annual Meeting of Stockholders | February 1, 2019 | 292 KB | Download |
| Quarterly Cash Flow Report | January 29, 2019 | 438 KB | Download |
| Quarterly Results and Investor Conference Call Notification | January 17, 2019 | 307 KB | Download |
| Disclosure of Interests for Allan Gray Australia | December 10, 2018 | 258 KB | Download |
| Osprey Medical, Inc. Awarded Premier Purchasing Agreement for DyeVert™ PLUS Contrast Reduction System | December 3, 2018 | 272 KB | Download |
| Allotment of Securities under Entitlement Offer | November 30, 2018 | 130 KB | Download |
| Completion of Entitlement Offer | November 28, 2018 | 291 KB | Download |
| Entitlement Offer – Update on Shortfall | November 19, 2018 | 289 KB | Download |
| Entitlement Offer – Extension of Closing Date | November 13, 2018 | 301 KB | Download |
| Osprey Medical – Notice of despatch of entitlement offer documents | November 7, 2018 | 852 KB | Download |
| Osprey Medical Inc. Secondary Trading Notice: Notice given under Section 708A(5)(e) of the Corporations Act | November 6, 2018 | 347 KB | Download |
| Osprey Medical Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b) | November 6, 2018 | 325 KB | Download |
| Appendix 3B: New issue announcement, application for quotation of additional securities and agreement | November 6, 2018 | 403 KB | Download |
| Completion of Private Placement | November 6, 2018 | 293 KB | Download |
| Entitlement Offer – Notice to Holders of CDIs | October 31, 2018 | 382 KB | Download |
| Entitlement Offer – Notification to Ineligible CDI Holders | October 31, 2018 | 443 KB | Download |
| Entitlement Offer – Notice to Optionholders | October 30, 2018 | 109 KB | Download |
| Capital raising of up to A$20.5m to accelerate GPO-focused growth strategy | October 30, 2018 | 377 KB | Download |
| Quarterly Cash Flow Report | October 30, 2018 | 765 KB | Download |
| Investor Presentation | October 30, 2018 | 3 MB | Download |
| Offer Booklet | October 30, 2018 | 301 KB | Download |
| Appendix 3B: New issue announcement, application for quotation of additional securities and agreement | October 30, 2018 | 182 KB | Download |
| Notice given under Section 708AA(2)(f) of the Corporations Act | October 30, 2018 | 148 KB | Download |
| Letter to Option Holders | October 30, 2018 | 105 KB | Download |
| Quarterly Results and Investor Conference Call Notification | October 25, 2018 | 313 KB | Download |
| Acute Kidney Injury in the spotlight at the world’s largest international cardiovascular conference TCT 2018 | September 26, 2018 | 101 KB | Download |
| Osprey Medical and GE Healthcare Launch New Educational Program to Increase Awareness of Strategies to Help Address Acute Kidney Injury (AKI) | September 20, 2018 | 406 KB | Download |
| Osprey Medical begins market access process to approve DyeVert™ Plus System in UK | September 7, 2018 | 241 KB | Download |
| Half Yearly Accounts Report | August 27, 2018 | 344 KB | Download |
| Quarterly Cash Flow Report | July 19, 2018 | 1 MB | Download |
| Results of 2018 Annual Meeting of Stockholders | May 10, 2018 | 127 KB | Download |
| 2018 Annual Meeting of Stockholders – Chairman’s Address and Presentation by President and CEO | May 10, 2018 | 2 MB | Download |
| Strong Recovery for DyeVert Plus in April 2018 | May 2, 2018 | 96 KB | Download |
| DyeVert Plus Featured at SCAI 2018 Scientific Session | April 30, 2018 | 2 MB | Download |
| Quarterly Cash Flow Report | April 26, 2018 | 1.9 MB | Download |
| ASX ANNOUNCEMENT – Notice of 2018 Annual Meeting of Stockholders & Proxy Statement | April 9, 2018 | 1 MB | Download |
| Osprey Medical National Kidney Month Programs | March 21, 2018 | 1 MB | Download |
| Osprey Medical Preliminary Final Report and Consolidated Financial Statements | February 26, 2018 | 470 KB | Download |
| Osprey Study chosen for “Best of Best” Presentation at Society for Cardiovascular Angiography and Interventions conference | February 16, 2018 | 141 KB | Download |
| 2018 Annual Meeting of Stockholders Announcement | February 6, 2018 | 89 KB | Download |
| Quarterly Cash Flow Report | January 24, 2018 | 2 MB | Download |
| Osprey Medical Highlights from TCT 2017 | November 3, 2017 | 108 KB | Download |
| Quarterly Cash Flow Report | October 16, 2017 | 1 MB | Download |
| Issue of securities to complete Placement and Entitlement Offer | September 4, 2017 | 98 KB | Download |
| Osprey Medical Inc. Secondary Trading Notice: Notice given under Section 708A(5)(e) of the Corporations Act | September 4, 2017 | 119 KB | Download |
| Osprey Medical Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b) | September 4, 2017 | 126 KB | Download |
| Successful completion of A$10.3 million entitlement offer | August 30, 2017 | 114 KB | Download |
| Entitlement Offer Closing Date | August 22, 2017 | 102 KB | Download |
| Half Yearly Accounts Report | August 21, 2017 | 188 KB | Download |
| Half Year Information for the Six Months Ended 30 June 2017 | August 21, 2017 | 205 KB | Download |
| Appendix 3B: New issue announcement, application for quotation of additional securities and agreement | August 18, 2017 | 186 KB | Download |
| Osprey Medical Inc. Amended and Restated Certificate of Incorporation | August 16, 2017 | 1 MB | Download |
| Osprey Medical – Notice to Nominees | August 15, 2017 | 587 KB | Download |
| Osprey Medical – Notice of despatch of entitlement offer documents | August 14, 2017 | 1,010 KB | Download |
| Osprey Medical Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b) | August 11, 2017 | 134 KB | Download |
| Private Placement Update | August 11, 2017 | 100 KB | Download |
| Appendix 3B: New issue announcement, application for quotation of additional securities and agreement | August 11, 2017 | 204 KB | Download |
| Secondary Trading Notice: Notice given under Section 708A(5)(e) of the Corporations Act | August 11, 2017 | 121 KB | Download |
| Osprey Entitlement Offer – notification to ineligible CDI holders | August 7, 2017 | 625 KB | Download |
| Entitlement Offer – notice to holders of CDIs | August 7, 2017 | 546 KB | Download |
| Appendix 3B: New issue announcement, application for quotation of additional securities and agreement | August 4, 2017 | 197 KB | Download |
| Osprey Medical Announces Successful Oversubscribed Placement and Fully Underwritten Entitlement Offer | August 4, 2017 | 149 KB | Download |
| Osprey Medical Inc. Entitlement Offer – Notice to Optionholders | August 4, 2017 | 112 KB | Download |
| Osprey Medical Inc. Offer Booklet | August 4, 2017 | 381 KB | Download |
| Cleansing Document | August 4, 2017 | 182 KB | Download |
| Capital Raising Presentation, August 2017 | August, 2017 | 3.3 MB | Download |
| Capital Raise Trading Halt | August 2, 2017 | 334 KB | Download |
| Quarterly Cash Flow Report | July 13, 2017 | 1 MB | Download |
| Osprey Medical increases addressable market with new DyeTect™ Automated Contrast Monitoring System | July 3, 2017 | 156 KB | Download |
| Medtronic VP and GM Sandra Lesenfants Joins Osprey Board | June 20, 2017 | 137 KB | Download |
| ASX ANNOUNCEMENT – Results of 2017 Annual Meeting of Stockholders | May 18, 2017 | 137 KB | Download |
| ASX ANNOUNCEMENT – 2017 Annual Meeting of Stockholders – Chairman’s Address and Presentation by President and CEO | May 18, 2017 | 5 MB | Download |
| Quarterly Cash Flow Report | April 18, 2017 | 2 MB | Download |
| Osprey Medical Receives US FDA Clearance for DyeVert™ PLUS | March 9, 2017 | 371 KB | Download |
| ASX ANNOUNCEMENT – Notice of Annual Meeting of Stockholders & Proxy Statement | April 24, 2017 | 963 KB | Download |
| Preliminary Final Report and Consolidated Financial Accounts | February 27, 2017 | 290 KB | Download |
| CEO Presentation December 2016 | December 2016 | 2 MB | Download |
| Osprey Introduces DyeVert PLUS at TCT | November 2, 2016 | 370 KB | Download |
| Osprey to Present at TCT 2016 | October 26, 2016 | 288 KB | Download |
| 4C Quarterly Cash Flow Report | October 14, 2016 | 2 MB | Download |
| ASX ANNOUNCEMENT – Completion of Private Placement | September 9, 2016 | 92 KB | Download |
| Appendix 3B: New issue announcement, application for quotation of additional securities and agreement | September 9, 2016 | 219 KB | Download |
| Change of Melbourne Address for Shareholder Purposes | September 9, 2016 | 108 KB | Download |
| Form 604: Notice of Change of Interests of Substantial Holder | September 9, 2016 | 331 KB | Download |
| Brandon Capital Partners – Change in Substantial Holding | September 9, 2016 | 213 KB | Download |
| Secondary Trading Notice: Notice given under Section 708A(5)(e) of the Corporations Act | September 9, 2016 | 114 KB | Download |
| ASX ANNOUNCEMENT – Security Purchase Plan Scale Back | September 7, 2016 | 107 KB | Download |
| ASX ANNOUNCEMENT – Partial Allocation Under Tranche 2 of Placement and Security Purchase Plan Update | September 6, 2016 | 104 KB | Download |
| Notice Given Under Section 708A(5)(e) of the Corporations Act | September 6, 2016 | 113 KB | Download |
| Appendix 3B: New issue announcement, application for quotation of additional securities and agreement | September 6, 2016 | 207 KB | Download |
| Results of Special Meeting of Stockholders | August 30, 2016 | 136 KB | Download |
| Half Year Accounts Report | August 29, 2016 | 518 KB | Download |
| Appendix 4D Half Year Report & Accounts | August 26, 2016 | 195 KB | Download |
| Notice of Special Meeting of Stockholders | August 18, 2016 | 452 KB | Download |
| Cleansing Document | August 11, 2016 | 121 KB | Download |
| Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b) | August 11, 2016 | 107 KB | Download |
| Appendix 3B: New issue announcement, application for quotation of additional securities and agreement | August 11, 2016 | 216 KB | Download |
| Share Purchase Plan | August 3, 2016 | 619 KB | Download |
| Revised CEO Capital Raising Presentation | August 4, 2016 | 2 MB | Download |
| Capital Raising Presentation, August 2016 | August 2016 | 5 MB | Download |
| Amended and Restated Certificate of Incorporation | August 4, 2016 | 1 MB | Download |
| Osprey Medical Announces Oversubscribed A$28 Million Private Placement | August 4, 2016 | 124 KB | Download |
| Response to ASX Price Query | July 29, 2016 | 500 KB | Download |
| CommSec Interview with CEO Mike McCormick | July 27, 2016 | 241 KB | Download |
| Key Sales Milestones | July 7, 2016 | 108 KB | Download |
| DyeVert Pilot Results presented at EuroPCR | May 20, 2016 | 215 KB | Download |
| 2016 AGM Results | May 12, 2016 | 137 KB | Download |
| June 2016 Newsletter | June 2016 | 2 MB | Download |
| AGM Chairman’s letter and CEO presentation | May 12, 2016 | 5 MB | Download |